Tag Archives: University of Wisconsin–Madison

Collaboration May Help Uncover Treatments for Rare Neurologic Disease

A research collaboration including scientists from the NIH’s National Center for Advancing Translational Sciences (NCATS) and the University of Wisconsin–Madison, helped identify three promising molecular compounds from a collection of approved drugs to pursue as potential treatments for Charcot-Marie-Tooth disease (CMT), a genetic neurological disease for which there are no current treatments. Continue reading

Posted in Charcot-Marie-Tooth disease, CMTA, Health CMT, human clinical trials, neuromuscular disease, peripheral neuropathy, stem cell research | Tagged , , , , , , , | 2 Comments

STAR’s Transformation Project

For the first time ever, live adult human stem cells will be used to search for effective compounds to treat CMT. The CMTA has embarked on this groundbreaking STAR research project to rapidly accelerate the drug development process in search of a successful treatment to slow, stop or potentially reverse the progression of CMT Continue reading

Posted in ALS, Alzheimer's, Charcot-Marie-Tooth disease, CMTA, Health CMT, human clinical trials, MS, neurological exam, Neurologist, neuromuscular disease, Parkinson's, peripheral neuropathy, STAR, stem cell research | Tagged , , , , , , , , | Leave a comment